Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China
· Delayed Price · Currency is CNY 6.77
+0.15 (2.27%)
Mar 10, 2026, 10:25 AM CST
SHE:300639 Revenue
Guangdong Hybribio Biotech had revenue of 170.88M CNY in the quarter ending September 30, 2025, a decrease of -15.14%. This brings the company's revenue in the last twelve months to 691.16M, down -20.01% year-over-year. In the year 2024, Guangdong Hybribio Biotech had annual revenue of 815.53M, down -26.16%.
Revenue (ttm)
691.16M
Revenue Growth
-20.01%
P/S Ratio
6.01
Revenue / Employee
313.45K
Employees
2,205
Market Cap
4.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 815.53M | -288.93M | -26.16% |
| Dec 31, 2023 | 1.10B | -4.49B | -80.27% |
| Jan 1, 2023 | 5.60B | 2.92B | 109.39% |
| Jan 1, 2022 | 2.67B | 1.32B | 97.34% |
| Dec 31, 2020 | 1.35B | 625.10M | 85.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Berry Genomics Co.,Ltd | 941.16M |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Thalys Medical Technology Group | 1.25B |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Chemclin Diagnostics | 353.32M |
| Cowealth Medical China | 777.03M |
| Maccura Biotechnology Co.Ltd | 2.21B |